TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Tumor necrosis factor-α (TNF-α) and interleukin-1 beta (IL-1β) are elevated in the vitreous of diabetic patients and in retinas of diabetic rats associated with increased retinal vascular permeability. However, the molecular mechanisms underlying retinal vascular permeability induced by these cytokines are poorly understood. In this study, the effects of IL-1β and TNF-α on retinal endothelial cell permeability were compared and the molecular mechanisms by which TNF-α increases cell permeability were elucidated. RESEARCH DESIGN AND METHODS: Cytokine-induced retinal vascular permeability was measured in bovine retinal endothelial cells (BRECs) and rat retinas. Western blotting, quantitative real-time PCR, and immunocytochemistry were performed to determine tight junction protein expression and localization. RESULTS: IL-1β and TNF-α increased BREC permeability, and TNF-α was more potent. TNF-α decreased the protein and mRNA content of the tight junction proteins ZO-1 and claudin-5 and altered the cellular localization of these tight junction proteins. Dexamethasone prevented TNF-α–induced cell permeability through glucocorticoid receptor transactivation and nuclear factor-kappaB (NF-κB) transrepression. Preventing NF-κB activation with an inhibitor κB kinase (IKK) chemical inhibitor or adenoviral overexpression of inhibitor κB alpha (IκBα) reduced TNF-α–stimulated permeability. Finally, inhibiting protein kinase C zeta (PKCζ) using both a peptide and a novel chemical inhibitor reduced NF-κB activation and completely prevented the alterations in the tight junction complex and cell permeability induced by TNF-α in cell culture and rat retinas. CONCLUSIONS: These results suggest that PKCζ may provide a specific therapeutic target for the prevention of vascular permeability in retinal diseases characterized by elevated TNF-α, including diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These molecules function to promote leukocyte recruitment, adhesion, and infiltration through the blood-retinal barrier, ultimately resulting in a breakdown of retinal immune privilege.15,16”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, neurovascular damage induced by the peripheral myeloid cells, pro-inflammatory cytokines, and the dysregulation of the complement pathways could be a further potential mechanism of action [36,37,38].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“0 RQ software and the 2 Ct analysis method (31), with glyceraldehyde-3-phosphate dehydrogenase (Bt03210919_g1) as the endogenous control.”
MethodBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“Gene deletion studies have shown claudin-5 to be essential for blood–brain barrier function (25), and likely for the BRB as well.”
BackgroundSignalling to and from tight junctions
Matter, K., & Balda, M. S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1055 · Cited by 884 · cited 1×
“Tight junctions are composed of a combination of more than 40 proteins including the transmembrane proteins occludin, the claudin family, and the junction adhesion molecule (JAM) family, several peripheral membrane-associated proteins, including members of the zonula occludens (ZO) family, and several regulatory prote…”
BackgroundUmeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S., Furuse, M., & Tsukita, S. (2006) · Cell · doi:10.1016/j.cell.2006.06.043 · Cited by 823 · cited 1×
“Recent studies demonstrated that ZO proteins are essential for the formation and organization of tight junction complex assembly (26,27).”
BackgroundMiyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., et al. (2006) · Diabetes · doi:10.2337/db05-1635 · Cited by 746
Self-citationAntonetti, D. A., Barber, A. J., Hollinger, L. A., Wolpert, E. B., & Gardner, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23463 · Cited by 686
Self-citationIkenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
The 14-year incidence of visual loss in a diabetic population,
Moss, S. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)96025-0 · Cited by 672
Cited by
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Self-citationInflammation in diabetic retinopathy
Tang, J., & Kern, T. S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.05.002 · Cited by 1,116
“TNFα likewise has been shown to increase retinal endothelial permeability increase via protein kinase C zeta (Aveleira et al., 2010).”
Mechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Current understanding of the molecular and cellular pathology of diabetic retinopathy
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00451-4 · Cited by 645
Self-citationClaudin-5: gatekeeper of neurological function
Greene, C., Hanley, N., & Campbell, M. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0123-z · Cited by 583
Glial influence on the blood brain barrier
Alvarez, J. I., Katayama, T., & Prat, A. (2013) · Glia · doi:10.1002/glia.22575 · Cited by 544
“…PKC(isomers) Fyn=Lyn and Rip which have a direct negative impact on the expression, transcription and stability of occludin, ZO-1 and claudin-5 (Aveleira et al., 2010; Stamatovic et al., 2008), as well as an indirect effect via activation of Snail (Wu et al., 2009b), which disrupts…”
BackgroundKomarova, Y. A., Kruse, K., Mehta, D., & Malik, A. B. (2017) · Circulation Research · doi:10.1161/circresaha.116.306534 · Cited by 503
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Altmann, C., & Schmidt, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010110 · Cited by 402
“TNFα also exerts a crucial role in BRB breakdown [213] and neuronal death, by increasing caspase-3 expression [214].”
BackgroundTan, G. S., Cheung, N., Simó, R., Cheung, G. C. M., & Wong, T. Y. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30052-3 · Cited by 361
The blood–retina barrier in health and disease
O’Leary, F., & Campbell, M. (2023) · The FEBS Journal · doi:10.1111/febs.16330 · Cited by 334
Cong, X., & Kong, W. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109485 · Cited by 302
Passing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
Dehdashtian, E., Mehrzadi, S., Yousefi, B., Hosseinzadeh, A., Reiter, R. J., Safa, M., Ghaznavi, H., & Naseripour, M. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.12.001 · Cited by 263
Rochfort, K. D., Collins, L. E., Murphy, R. P., & Cummins, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101815 · Cited by 261
Mind the gap: mechanisms regulating the endothelial barrier
Radeva, M. Y., & Waschke, J. (2018) · Acta Physiologica · doi:10.1111/apha.12860 · Cited by 249
Palmer, A. L., & Ousman, S. S. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00337 · Cited by 250
The blood–brain barrier endothelium: a target for pro-inflammatory cytokines
Rochfort, K. D., & Cummins, P. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20140319 · Cited by 245
Retinal microglia – A key player in healthy and diseased retina
Rathnasamy, G., Foulds, W. S., Ling, E.-A., & Kaur, C. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.05.006 · Cited by 242
“TNF-α and IL-1β have been reported to increase leukocyte adhesion to retinal endothelium, increase the permeability at the iBRB and cause degeneration of retinal capillaries (Aveleira et al., 2010; Kowluru and Odenbach, 2004).”
BackgroundNovel approaches for treating diabetic retinopathy based on recent pathogenic evidence
Simó, R., & Hernández, C. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.04.003 · Cited by 239
Bucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
RETINAL VASCULAR CYSTOID MACULAR EDEMA: Review and New Theory
Spaide, R. F. (2016) · Retina · doi:10.1097/iae.0000000000001158 · Cited by 229
Contribution of Microglia‐Mediated Neuroinflammation to Retinal Degenerative Diseases
Madeira, M. H., Boia, R., Santos, P. F., Ambrósio, A. F., & Santiago, A. R. (2015) · Mediators of Inflammation · doi:10.1155/2015/673090 · Cited by 227
Self-citationEndothelial Dysfunction in Diabetic Retinopathy
Gui, F., You, Z., Fu, S., Wu, H., & Zhang, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00591 · Cited by 207
Omri, S., Behar-Cohen, F., de Kozak, Y., Sennlaub, F., Mafra Verissimo, L., Jonet, L., Savoldelli, M., Omri, B., & Crisanti, P. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.018 · Cited by 213
Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy
Rudraraju, M., Narayanan, S. P., & Somanath, P. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105115 · Cited by 217
Tight junctions in pulmonary epithelia during lung inflammation
Wittekindt, O. H. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1917-3 · Cited by 210
Mechanistic Insights into Pathological Changes in the Diabetic Retina
Roy, S., Kern, T. S., Song, B., & Stuebe, C. (2017) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.08.022 · Cited by 206
Manu, D. R., Slevin, M., Barcutean, L., Forro, T., Boghitoiu, T., & Balasa, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417146 · Cited by 181
“Inhibition of IKK or protein kinase C zeta (PKC ζ ) blocks this effect on TJ proteins [97].”
The Role of Microglia in Diabetic Retinopathy
Grigsby, J. G., Cardona, S. M., Pouw, C. E., Muniz, A., Mendiola, A. S., Tsin, A. T. C., Allen, D. M., & Cardona, A. E. (2014) · Journal of Ophthalmology · doi:10.1155/2014/705783 · Cited by 196
Nawaz, I. M., Rezzola, S., Cancarini, A., Russo, A., Costagliola, C., Semeraro, F., & Presta, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.03.002 · Cited by 195
Jia, Z., Nallasamy, P., Liu, D., Shah, H., Li, J. Z., Chitrakar, R., Si, H., McCormick, J., Zhu, H., Zhen, W., et al. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.11.008 · Cited by 190
Oxidative Stress‐Related Mechanisms and Antioxidant Therapy in Diabetic Retinopathy
Li, C., Miao, X., Li, F., Wang, S., Liu, Q., Wang, Y., & Sun, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9702820 · Cited by 184
Inflammatory and angiogenic biomarkers in diabetic retinopathy
Kaštelan, S., Orešković, I., Bišćan, F., Kaštelan, H., & Gverović Antunica, A. (2020) · Biochemia medica · doi:10.11613/bm.2020.030502 · Cited by 178
Alsaffar, H., Martino, N., Garrett, J. P., & Adam, A. P. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00235.2017 · Cited by 173
“In addition, mechanisms such as NF- B-dependent transcriptional regulation are known to contribute to the loss of barrier function hours after treatment with proinflammatory cytokines such as tumor necrosis factor (TNF)- (5, 11, 67).”
BackgroundInflammation and diabetic retinal microvascular complications
Zhang, W., Liu, H., Al-Shabrawey, M., Caldwell, R. W., & Caldwell, R. B. (2011) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.83035 · Cited by 183
Diabetic retinopathy: Breaking the barrier
Eshaq, R. S., Aldalati, A. M. Z., Alexander, J. S., & Harris, N. R. (2017) · Pathophysiology · doi:10.1016/j.pathophys.2017.07.001 · Cited by 169
C-Reactive protein as a biomarker for major depressive disorder?
Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171
Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach
Vujosevic, S., & Simó, R. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-21769 · Cited by 165
“TNF-a is a cytokine that promotes the irreversible adhesion of leukocytes to the endothelium (leukostasis), increases the production of reactive oxygen species, and is implicated in the blood-retinal barrier breakdown.(18,19) Baseline circulating TNFa was a predictor of DR incidence,(20) as well as of diabetic complic…”
BackgroundYu, H., Huang, X., Ma, Y., Gao, M., Wang, O., Gao, T., Shen, Y., & Liu, X. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6996 · Cited by 149
Wang, B., Feng, L., Jiang, W.-D., Wu, P., Kuang, S.-Y., Jiang, J., Tang, L., Tang, W.-N., Zhang, Y.-A., Liu, Y., et al. (2015) · Aquatic Toxicology · doi:10.1016/j.aquatox.2014.10.025 · Cited by 165
The role of inflammation in diabetic eye disease
Mesquida, M., Drawnel, F., & Fauser, S. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00750-7 · Cited by 170
Ischemic Retinopathies: Oxidative Stress and Inflammation
Rivera, J. C., Dabouz, R., Noueihed, B., Omri, S., Tahiri, H., & Chemtob, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3940241 · Cited by 160
“It has been shown that TNFα directly contributes to BRB breakdown in DR by activating PKC-ζ/NF-κB pathway which reduces the expression of tight junction proteins claudin-5 and ZO-1 and increases endothelial cell permeability [144].”
BackgroundSinclair, S. H., & Schwartz, S. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00843 · Cited by 170
Petecchia, L., Sabatini, F., Usai, C., Caci, E., Varesio, L., & Rossi, G. A. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.67 · Cited by 162
“Evidence suggests that these signaling activities may affect TJs by inducing phosphorylation and regulation of protein–protein interactions.(50)”
BackgroundDexamethasone intravitreal implant in the treatment of diabetic macular edema
Dugel, P. U., Bandello, F. M., & Loewenstein, A. (2015) · Clinical ophthalmology · doi:10.2147/opth.s79948 · Cited by 159
Zhang, T., Ouyang, H., Mei, X., Lü, B., Yu, Z., Chen, K., Wang, Z., & Ji, L. (2019) · The FASEB Journal · doi:10.1096/fj.201802614rrr · Cited by 150
“the leukocyte adherence, damaged the TJ complex, and finally induced BRB breakdown (53).”
BackgroundAlterations to the Blood–Retinal Barrier in Diabetes: Cytokines and Reactive Oxygen Species
Frey, T., & Antonetti, D. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.3906 · Cited by 137
Self-citationChen, T., Kim, C. Y., Kaur, A., Lamothe, L., Shaikh, M., Keshavarzian, A., & Hamaker, B. R. (2017) · Food & Function · doi:10.1039/c6fo01532h · Cited by 137
Aslam, M., Ahmad, N., Srivastava, R., & Hemmer, B. (2011) · Cytokine · doi:10.1016/j.cyto.2011.10.016 · Cited by 153
Anti-Inflammatory Therapy for Diabetic Retinopathy
Zhang, W., Liu, H., Rojas, M., Caldwell, R. W., & Caldwell, R. B. (2011) · Immunotherapy · doi:10.2217/imt.11.24 · Cited by 134
Autophagy in Diabetic Retinopathy
Rosa, M. D., Distefano, G., Gagliano, C., Rusciano, D., & Malaguarnera, L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160321122900 · Cited by 145
“TNFα has been found increased in the vitreous of diabetic patients [38] and in diabetic rat retinas [39] and through protein kinase C (PKC) and nuclear factorkappa B (NF-κB) signals impairs the tight junction complex and alters retinal endothelial cell permeability [40].”
BackgroundRigor, R. R., Shen, Q., Pivetti, C. D., Wu, M. H., & Yuan, S. Y. (2013) · Medicinal Research Reviews · doi:10.1002/med.21270 · Cited by 130
Yun, J., Park, S. W., Kim, K., Bae, J., Lee, E. H., Paek, S. H., Kim, S. U., Ye, S., Kim, J., & Cho, C. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25575 · Cited by 128
“We found that the mRNA transcripts of IL-1 (Il6), IL-1b (Il1b), and TNF-a (Tnfa) were increased from 1 to 3 months in the STZ-induced diabetic retinas (Fig.”
InfluentialPharmacology of Corticosteroids for Diabetic Macular Edema
Whitcup, S. M., Cidlowski, J. A., Csaky, K. G., & Ambati, J. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22259 · Cited by 144
Modulation of three key innate immune pathways for the most common retinal degenerative diseases
Akhtar‐Schäfer, I., Wang, L., Krohne, T. U., Xu, H., & Langmann, T. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708259 · Cited by 129
“Leakage of the retinal vasculature is mainly induced by VEGF, but also involves TNF-a , which decreases the expression of tight junction proteins ZO-1 and claudin-5 (Behl et al, 2008; Aveleira et al, 2010).”
BackgroundWu, H. M., Chen, Q.-Y., Wang, W., Chu, S., Liu, X., Liu, Y., Tan, C., Zhu, F., Deng, S., Dong, Y., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110937 · Cited by 125
Jiang, J., Yin, L. W., Li, J.-Y., Li, Q., Shi, D., Feng, L., Liu, Y., Jiang, W., Wu, P., Zhao, Y., et al. (2017) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2017.09.035 · Cited by 120
The innate immune system in diabetic retinopathy
Pan, W. W., Lin, F., & Fort, P. E. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100940 · Cited by 125
Xu, H.-J., Jiang, W., Feng, L., Liu, Y., Wu, P., Jiang, J., Kuang, S., Tang, L., Tang, W., Zhang, Y., et al. (2016) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2016.02.033 · Cited by 121
Zheng, X., Ren, B., & Gao, Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115272 · Cited by 121
del Valle, M. L., Dworshak, J., Sharma, A. K., Ibrahim, A. S., Al‐Shabrawey, M., & Sharma, S. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.09.009 · Cited by 117
“The increase in BRB permeability is associated with changes in the expression of tight junctions in retinal vessels (Aveleira et al., 2010; Barber and Antonetti, 2003; Campbell and Humphries, 2011; Dejana et al., 2008).”
BackgroundNutraceuticals for the Treatment of Diabetic Retinopathy
Rossino, M. G., & Casini, G. (2019) · Nutrients · doi:10.3390/nu11040771 · Cited by 111
Regulation of paracellular permeability: factors and mechanisms
Hu, Y.-J., Wang, Y., Tan, F.-Q., & Yang, W. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2724-y · Cited by 129
Wang, H. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i18.2180 · Cited by 111
The role of protein kinase C in diabetic microvascular complications
Pan, D., Xu, L., & Guo, M. H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.973058 · Cited by 131
Kobayashi, K., Oyama, S., Numata, A., Rahman, M. M., & Kumura, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062187 · Cited by 119
Cardoso, F. L., Kittel, Á., Veszelka, S., Palmela, I., Tóth, A., Brites, D., Deli, M. A., & Brito, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035919 · Cited by 110
“In fact, the mRNA contents of TJ proteins ZO-1 and claudin-5, as well as their cellular localization decrease in bovine retinal endothelial cells treated by IL-1b and TNF-a [77], which are known to be secreted by astrocytes.”
BackgroundMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Bolinger, M. T., & Antonetti, D. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091498 · Cited by 114
“In TNF-α treated BREC, mRNA and protein levels of the TJ proteins ZO-1 and claudin-5 are decreased, along with mis-localization of both proteins and a corresponding increase in permeability [76].”
BackgroundSelf-citationCoelho-Santos, V., Leitão, R. A., Cardoso, F. L., Palmela, I., Rito, M., Barbosa, M., Brito, M. A., Fontes-Ribeiro, C. A., & Silva, A. P. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.59 · Cited by 104
Targeting endothelial tight junctions to predict and protect thoracic aortic aneurysm and dissection
Yang, X., Chen, X., Yao, F., Ding, Q., Liu, H., Luo, C., Wang, D., Huang, J., Li, Z., Shen, Y., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac823 · Cited by 109
Vujosevic, S., Micera, A., Bini, S., Berton, M., Esposito, G., & Midena, E. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12812 · Cited by 113
Clark, P. R., Kim, R. K., Pober, J. S., & Kluger, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120075 · Cited by 115
Latorre, J. D., Adhikari, B., Park, S. H., Teague, K. D., Graham, L. E., Mahaffey, B. D., Baxter, M. F. A., Hernández-Velasco, X., Kwon, Y. M., Ricke, S. C., et al. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00199 · Cited by 106
Yamamoto, M., Guo, D.-H., Hernandez, C. M., & Stranahan, A. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2506-18.2019 · Cited by 94
“, 2008) and in diabetic retinopathy, downregulation of endothelial claudin-5 was shown to be NFKb-dependent (Aveleira et al., 2010).”
BackgroundRidzuan, N., Zakaria, N., Widera, D., Sheard, J., Morimoto, M., Kiyokawa, H., Isa, S. A. M., Singh, G. K. C., Then, K.-Y., Ooi, G., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02088-6 · Cited by 116
Haydinger, C. D., Ferreira, L. B., Williams, K. A., & Smith, J. R. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1128811 · Cited by 110
Li, C.-H., Shyu, M.-K., Jhan, C., Cheng, Y.-W., Tsai, C.-H., Liu, C.-W., Lee, C.-C., Chen, R.-M., & Kang, J.-J. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv176 · Cited by 95
“Stimuli such as TNF-a (Aveleira et al., 2010), VEGF (Titchenell et al., 2012), hyperglycemia (Omri et al., 2013), and hypoxia (Willis et al., 2010), which induce the hyper-activation of PKCf, subsequently compromise TJ complexes.”
BackgroundMuthusamy, A., Lin, C.-M., Shanmugam, S., Lindner, H., Abcouwer, S. F., & Antonetti, D. A. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.230 · Cited by 105
Self-citationUsefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
Simó‐Servat, O., Hernández, C., & Simó, R. (2012) · Mediators of Inflammation · doi:10.1155/2012/872978 · Cited by 101
“This is a serious limiting factor because the participation of either angiogenic factors (i.e., VEGF) or proinflammatory cytokines is highly variable in both PDR and DME.”
BackgroundInfluentialWang, J., Wei, Z., Zhang, X., Wang, Y., Fu, Y., & Yang, Z. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13976 · Cited by 95
“Moreover, some studies (Aveleira et al., 2010; Kamekura et al., 2010; Tang et al., 2010; Choi et al., 2012) have indicated that the activation of the NF-κB pathway increases tight junction permeability.”
BackgroundShanmuganathan, S., & Angayarkanni, N. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2018.04.005 · Cited by 98
Wu, D., Cerutti, C., Lopez-Ramirez, M. A., Pryce, G., King-Robson, J., Simpson, J. E., van der Pol, S. M., Hirst, M. C., de Vries, H. E., Sharrack, B., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.207 · Cited by 89
Yamazaki, Y., Shinohara, M., Yamazaki, A., Ren, Y., Asmann, Y. W., Kanekiyo, T., & Bu, G. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313169 · Cited by 89
Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy
Santiago, A. R., Boia, R., Aires, I. D., Ambrósio, A. F., & Fernandes, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00820 · Cited by 97
“TNF also increases retinal endothelial cell monolayer permeability by inducing a decrease in the tight junction proteins zonula occludens (ZO)-1 and claudin-5 and a localization shift of both proteins (Aveleira et al., 2010).”
BackgroundSelf-citationCirculating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
Simó‐Servat, O., Simó, R., & Hernández, C. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5263798 · Cited by 97
Wesselingh, R., Butzkueven, H., Buzzard, K., Tarlinton, D., O'Brien, T. J., & Monif, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02066 · Cited by 83
Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
Santiago, A. R., Baptista, F. I., Santos, P. F., Cristóvão, G., Ambrósio, A. F., Cunha, R. A., & Gomes, C. A. (2014) · Mediators of Inflammation · doi:10.1155/2014/465694 · Cited by 93
Self-citationTonade, D., Liu, H., Palczewski, K., & Kern, T. S. (2017) · Diabetologia · doi:10.1007/s00125-017-4381-5 · Cited by 84
The Role of Müller Cells in Diabetic Macular Edema
Lai, D., Wu, Y., Shao, C., & Qiu, Q. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.10.8 · Cited by 86
Miranda, S., González‐Rodríguez, Á., García‐Ramírez, M., Revuelta‐Cervantes, J., Hernández, C., Simó, R., & Valverde, Á. M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22970 · Cited by 82
“This proinflammatory cytokine signals through protein kinase C (PKC) z and nuclear factor-kappaB (NF-kB) to alter the tight junction complex and increase retinal endothelial cell permeability (Aveleira et al., 2010).”
BackgroundMahmoud, A. M., El-Twab, S. M. A., & Abdel-Reheim, E. S. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1214-0 · Cited by 83
Yue, Q., & Hoi, M. P. M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367832 · Cited by 107
“The BBB destabilizing effects of proinflammatory cytokines through signaling to NF-κB via protein kinase C (PKC) (Aveleira et al., 2010), PI3K/AKT (Min et al., 2007), receptor-interacting protein (Downes and Crack, 2010; Savard et al., 2015) and the Src family kinases Fyn/Lyn (Gong et al., 2008)…”
InfluentialJeon, M.-T., Kim, K.-S., Kim, E. S., Lee, S., Kim, J., Hoe, H.-S., & Kim, D.-G. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101333 · Cited by 76
Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy
Simó, R., Simó‐Servat, O., Bogdanov, P. M., & Hernández, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13081320 · Cited by 80
Benmoussa, A., Diallo, I., Salem, M., Michel, S., Gilbert, C., Sévigny, J., & Provost, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-51092-1 · Cited by 81
Baruch, K., Kertser, A., Porat, Z., & Schwartz, M. (2015) · The EMBO Journal · doi:10.15252/embj.201591468 · Cited by 75
“Closer examination of the epithelial monolayer morphology showed that exposure to TNF a resulted in disturbance of ZO-1 tight junction protein localization, as previously observed (Ma et al , 2004; Aveleira et al , 2010), and that this effect was attenuated by the DETA pre-treatment (Fig 3E).”
Pericytes enable effective angiogenesis in the presence of proinflammatory signals
Kang, T.-Y., Bocci, F., Jolly, M. K., Levine, H., Onuchic, J. N., & Levchenko, A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913373116 · Cited by 78
López-Contreras, A. K., Martínez-Ruíz, M. G., Olvera-Montaño, C., Robles-Rivera, R. R., Arévalo-Simental, D. E., Castellanos‐González, J. A., Hernández-Chávez, A., Huerta-Olvera, S. G., Cardona-Muñóz, E. G., & Rodríguez-Carrizález, A. D. (2020) · Antioxidants · doi:10.3390/antiox9090891 · Cited by 83
Metadata
- Authors
- Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A.
- Affiliations
- Pennsylvania State University (US)
- Centro de Neurociências e Biologia Celular (PT)
- Corresponding author
- Aveleira, Célia A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-06
- Volume
- 59
- Issue
- 11
- Pages
- 2872-2882
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963546
- OpenAlex
- W2155144135
- Cited by
- 403
- References
- 57
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 17 · 2023: 26 · 2022: 31 · 2021: 33 · 2020: 34 · 2019: 35 · 2018: 35 · 2017: 31 · 2016: 23 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 20
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Juvenile Diabetes Research Foundation International
- University of Pennsylvania
- Pennsylvania State University
- National Institutes of Health (012021)
- Penn State College of Medicine
- National Eye Institute (R01EY012021, R01EY016413)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- TNF-α, IL-1β, tight junction proteins, ZO-1, claudin-5, protein kinase C, NF-κB signaling, dexamethasone, glucocorticoid receptor, IκBα, diabetic retinopathy, retinal vascular permeability, IKK inhibitor
- MeSH terms
- Protein Kinase C zeta, Animals, Cattle, Cell Membrane Permeability, Dexamethasone, Diabetic Retinopathy, Humans, Male, Permeability, Protein Kinase C, Retina, Retinal Diseases, Tumor Necrosis Factor-alpha, NF-kappa B, Rats, Sprague-Dawley, Tight Junctions, Endothelial Cells, Rats, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.